| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |